Bupartek

Bupartek is a veterinary injectable solution formulated for the effective treatment of Theileriosis in racing horses and camels. It acts rapidly against multiple species of Theileria, helping control parasitic infections and restore animal health and performance.

Active Ingredient:

• Buparvaquone (Concentration as per manufacturer specifications)

Targeted Parasites:

• Theileria annulata

• Theileria parva

• Theileria mutans

• Theileria sergenti

Indications:
Bupartek is indicated for the treatment of clinical and subclinical Theileriosis in susceptible species. It is effective both during the incubation phase and after the onset of clinical symptoms.

Dosage and Administration:

• Dosage: 2.5 mg/kg body weight

• Administration: Deep intramuscular injection

• Dosing volume: Approximately 1 mL per 20 kg body weight

• Note: Do not inject more than 10 mL per site. If the required volume exceeds this, divide into multiple injection sites.

Key Benefits:

• Rapid parasite elimination

• Effective across Theileria species

• Single-dose convenience

• Suitable for early or late-stage infection

• Promotes faster clinical recovery

Usage Recommendations:

• Use under veterinary supervision only

• Ensure accurate dosing based on weight

• Monitor clinical response post-treatment

• Repeat dose only if advised by a veterinarian

Withdrawal Period:

• Meat: 42 days

• Not approved for lactating dairy animals producing milk for human use

Treats all theileriosis forms
Fast symptom relief
Effective single-dose option
Supports early intervention
Targets key Theileria strains

each ml : contains 50 mg of buparvaquone